Literature DB >> 25495147

The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications.

Jurij Fürst1, Milan Čižman, Jana Mrak, Damjan Kos, Stephen Campbell, Samuel Coenen, Lars L Gustafsson, Luka Fürst, Brian Godman.   

Abstract

INTRODUCTION: Rising antibiotic resistance has become an increasing public health problem. There is a well-established correlation between antibiotic consumption and antimicrobial resistance. Consequently, measures to rationalize the prescribing of antibiotics should reduce the resistant strains. Following a 24% increase in antibiotic consumption at the end of the 1990s, multiple activities were designed and introduced by the Health Insurance Institute of Slovenia (ZZZS) and other organizations in Slovenia at the end of 1999. These activities reduced the antibiotic consumption by 18.7% by 2002. These measures have continued.
OBJECTIVE: To study changes in antibiotic utilization from 1995 to 2012 alongside the multiple interventions and their consequences, including changes in resistance patterns.
METHODS: This was a retrospective observational study involving all patients dispensed at least one ZZZS prescription for an antibiotic in Slovenia. Utilization was expressed in defined daily doses per thousand inhabitants per day. Multifaceted interventions were conducted over time involving all key stakeholder groups, that is, the Ministry of Health, ZZZS, physician groups and patients. These included comprehensive communication programs as well as prescribing restrictions for a number of antibiotics and classes.
RESULTS: From 1999 to 2012, antibiotic consumption decreased by 2-9% per year, with an overall decrease of 31%. There were also appreciable structural changes. Overall antibiotic utilization and the utilization of 7 out of 10 antibiotics significantly decreased after multiple interventions. The resistance of Streptococcus pneumoniae to penicillin decreased in line with decreased utilization. However, its resistance to macrolides increased from 5.4 to 21% despite halving of its utilization. The resistance of Escherichia coli to fluoroquinolones doubled from 10 to 21% despite utilization decreasing by a third. Expenditures on antibiotics decreased by 53%.
CONCLUSION: Multiple demand-side measures introduced following increased utilization significantly decreased subsequent antibiotic utilization and associated costs. However, there was variable impact on antibiotic resistance. Additional targeted activities are planned to further reduce antibiotic prescribing and resistance.

Entities:  

Keywords:  Slovenia; antibiotic resistance; antibiotic use; drug utilization; multifaceted interventions; policies; rational use of antibiotics

Mesh:

Substances:

Year:  2014        PMID: 25495147     DOI: 10.1586/14787210.2015.990381

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  24 in total

1.  Trends in paediatric macrolide use in five European countries-a population-based study.

Authors:  Jakob Holstiege; Dirk Enders; Tania Schink; Francesco Innocenti; Alessandro Oteri; Irene Bezemer; Florentia Kaguelidou; Mariam Molokhia; Elisabetta Poluzzi; Aurora Puccini; Sinna Pilgaard Ulrichsen; Miriam C Sturkenboom; Gianluca Trifirò; Edeltraut Garbe
Journal:  Eur J Clin Pharmacol       Date:  2015-05-22       Impact factor: 2.953

2.  Effects of prescription restrictive interventions on antibiotic procurement in primary care settings: a controlled interrupted time series study in China.

Authors:  Yuqing Tang; Chaojie Liu; Zinan Zhang; Xinping Zhang
Journal:  Cost Eff Resour Alloc       Date:  2018-01-16

3.  Antibiotic prescribing frequency amongst patients in primary care: a cohort study using electronic health records.

Authors:  Laura Shallcross; Nick Beckley; Greta Rait; Andrew Hayward; Irene Petersen
Journal:  J Antimicrob Chemother       Date:  2017-06-01       Impact factor: 5.790

4.  Initiatives to Reduce Nonprescription Sales and Dispensing of Antibiotics: Findings and Implications.

Authors:  Vanda Marković-Peković; Nataša Grubiša; Johanita Burger; Ljubica Bojanić; Brian Godman
Journal:  J Res Pharm Pract       Date:  2017 Apr-Jun

5.  Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children.

Authors:  Tita Butenko; Samo Jeverica; Rok Orel; Matjaž Homan
Journal:  Helicobacter       Date:  2017-06-27       Impact factor: 5.753

6.  Antibiotic consumption and antimicrobial resistance in Poland; findings and implications.

Authors:  Jadwiga Wojkowska-Mach; Tomasz Bochenek; Brian Godman; Amanda Glassman; Amanj Kurdi; Andrzej Pilc; Anna Rozanska; Szymon Skoczyński; Marta Wałaszek
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-15       Impact factor: 4.887

7.  The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future.

Authors:  Brian Godman; Mainul Haque; Trudy Leong; Eleonora Allocati; Santosh Kumar; Salequl Islam; Jaykaran Charan; Farhana Akter; Amanj Kurdi; Carlos Vassalo; Muhammed Abu Bakar; Sagir Abdur Rahim; Nusrat Sultana; Farzana Deeba; M A Halim Khan; A B M Muksudul Alam; Iffat Jahan; Zubair Mahmood Kamal; Humaira Hasin; Shamsun Nahar; Monami Haque; Siddhartha Dutta; Jha Pallavi Abhayanand; Rimple Jeet Kaur; Godfrey Mutashambara Rwegerera; Renata Cristina Rezende Macedo do Nascimento; Isabella Piassi Dias Godói; Mohammed Irfan; Adefolarin A Amu; Patrick Matowa; Joseph Acolatse; Robert Incoom; Israel Abebrese Sefah; Jitendra Acharya; Sylvia Opanga; Lisper Wangeci Njeri; David Kimonge; Hye-Young Kwon; SeungJin Bae; Karen Koh Pek Khuan; Abdullahi Rabiu Abubakar; Ibrahim Haruna Sani; Tanveer Ahmed Khan; Shahzad Hussain; Zikria Saleem; Oliver Ombeva Malande; Thereza Piloya-Were; Rosana Gambogi; Carla Hernandez Ortiz; Luke Alutuli; Aubrey Chichonyi Kalungia; Iris Hoxha; Vanda Marković-Peković; Biljana Tubic; Guenka Petrova; Konstantin Tachkov; Ott Laius; András Harsanyi; András Inotai; Arianit Jakupi; Svens Henkuzens; Kristina Garuoliene; Jolanta Gulbinovič; Magdalene Wladysiuk; Jakub Rutkowski; Ileana Mardare; Jurij Fürst; Stuart McTaggart; Sean MacBride-Stewart; Caridad Pontes; Corinne Zara; Eunice Twumwaa Tagoe; Rita Banzi; Janney Wale; Mihajlo Jakovljevic
Journal:  Front Public Health       Date:  2021-06-24

8.  Changes in Availability, Utilization, and Prices of Medicines and Protection Equipment for COVID-19 in an Urban Population of Northern Nigeria.

Authors:  Mainul Haque; Abdullahi Rabiu Abubakar; Olayinka O Ogunleye; Ibrahim Haruna Sani; Israel Sefah; Amanj Kurdi; Salequl Islam; Brian Godman
Journal:  J Res Pharm Pract       Date:  2021-05-13

9.  Irrational Use of Medicines-A Summary of Key Concepts.

Authors:  Richard Ofori-Asenso; Akosua Adom Agyeman
Journal:  Pharmacy (Basel)       Date:  2016-10-28

10.  Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications.

Authors:  Ljubica Bojanić; Vanda Marković-Peković; Ranko Škrbić; Nataša Stojaković; Mirjana Ðermanović; Janja Bojanić; Jurij Fürst; Amanj B Kurdi; Brian Godman
Journal:  Front Pharmacol       Date:  2018-05-29       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.